Please login to the form below

Not currently logged in
Email:
Password:

Vokanamet

This page shows the latest Vokanamet news and features for those working in and with pharma, biotech and healthcare.

FDA approves J&J’s diabetes combo

FDA approves J&J’s diabetes combo

The FDA approval follows the decision by the European Commission in April this year to approval a combination of canagliflozin and metformin under the name Vokanamet.

Latest news

  • Boehringer/Lilly's Jardiance approved in US Boehringer/Lilly's Jardiance approved in US

    Both these products are also available as combination treatments with metformin in versions called Vokanamet (Invokana and metformin) and Xigduo (Forxiga and metformin).

  • NICE backs Janssen’s once-daily diabetes drug NICE backs Janssen’s once-daily diabetes drug

    Janssen's Invokana was also granted European approval for a fixed dose combination with metformin that will be marketed as Vokanamet, putting it on an equal setting to AstraZeneca, which markets

  • EC approves drugs for diabetes and Crohn’s disease EC approves drugs for diabetes and Crohn’s disease

    Both these products are also available as combination treatments with metformin in versions called Vokanamet (Invokana and metformin) and Xigduo (Forxiga and metformin).

  • J&J wins EU approval for diabetes combo J&J wins EU approval for diabetes combo

    Vokanamet combines Invokana and metformin. Johnson &Johnson's diabetes portfolio continues to grow apace with the news that its combination treatment Vokanamet has been approved in the EU. ... Vokanamet combines J&J's already-available Invokana

  • Janssen Invokana combination recommended for European approval Janssen Invokana combination recommended for European approval

    The CHMP's positive opinion on Vokanamet puts the type 2 diabetes treatment on the path to full approval in the region within the next three months. ... The company will have to implement a pharmacovigilance plan for Vokanamet as part of any marketing

More from news
Approximately 2 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics